Verona Pharma Plc - ADR (VRNA) Company Profile & Statistics

Verona Pharma Plc - ADR
VRNA
(Nasdaq - US)
Closed
35.66
+0.29 (+0.82%)
in:usd•As of: Nov 15, 2024 15:59 UTC -5
Pre Market:0+0.00 (0.00%)
Open
34.83
High
35.96
Low
34.80

About Verona Pharma Plc - ADR

CEO

David Zaccardelli

Headquarters

3 more london riverside

london, x0 se1 2re, united kingdom

Auditor

PricewaterhouseCoopers LLP

Employees

Share Holders

N/A

Website

www.veronapharma.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Verona Pharma plc is a clinical-stage biopharmaceutical company. It researches, discovers and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. Verona Pharma plc is based in London, the United Kingdom.

Verona Pharma Plc - ADR Statistics

Valuation Measures

Market Capitalization ²	2.85B
Enterprise Value	2.64B
Enterprise Value/EBITDA (ttm)	-17.16
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	22.20
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	22.59%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-190.98%
Return on Equity (ttm)	-79.54%
Return on Invested Capital (ttm)	-55.63%
Return on Assets (ttm)	-43.49%

Income Statement

Revenue (ttm)	5.62M
Revenue Per Share (ttm)	0.07
Gross Profit (ttm)	5.08M
EBITDA (ttm)³	-153.59M
Net Income Avi to Common (ttm)	-153.72M
Diluted EPS (ttm)	-1.92

Share Statistics

Beta (5Y Monthly)	0.42
52-Week Change	142.09%
S&P500 52-Week Change	29.10%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	81.83M
Dividend Yield	0.00%
Float ⁴	76.10M
% Held by Insiders	4.80%
% Held by Institutions	85.88%

Balance Sheet

Total Cash (mrq)	336.04M
Total Cash Per Share (mrq)	4.11
Total Debt (mrq)	121.36M
Total Debt/Equity (mrq)	93.00%
Current Ratio (mrq)	13.03%
Quick Ratio (mrq)	12.88%
Book Value Per Share (mrq)	1.59

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.15
Free Cash Flow (ytd)	-93.41M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Verona Pharma Plc - ADR

Trade With A Regulated Broker